| P2093 | author name string | Mohammadreza Bigdeli | |
| | Yadollah Shakiba | |
| | Khosro Sadeghniiat | |
| | Samaneh Sheikhi Kouhsar | |
| P2860 | cites work | An updated meta-analysis of endothelial nitric oxide synthase gene: three well-characterized polymorphisms with hypertension | Q21135238 |
| | Nitric Oxide as a Unique Bioactive Signaling Messenger in Physiology and Pathophysiology | Q24805828 |
| | Obstructive sleep apnea and cognitive impairment: addressing the blood-brain barrier | Q26849304 |
| | Role of nitric oxide after brain ischaemia | Q28208960 |
| | A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale | Q28256570 |
| | NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases | Q28264121 |
| | Management of obstructive sleep apnea in adults: A clinical practice guideline from the American College of Physicians | Q28299093 |
| | The A930G polymorphism ofP22phox (CYBA) gene but not C242T variation is associated with hypertension: a meta-analysis | Q28304274 |
| | GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence | Q28567229 |
| | Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force | Q29615535 |
| | Polymorphisms in nitric oxide synthase and endothelin genes among children with obstructive sleep apnea | Q31137190 |
| | Current trends in the development of nitric oxide donors. | Q33676979 |
| | Tetrahydrobiopterin in cardiovascular health and disease | Q33687812 |
| | NADPH oxidases: functions and pathologies in the vasculature | Q33739287 |
| | GTP cyclohydrolase I gene polymorphisms are associated with endothelial dysfunction and oxidative stress in patients with type 2 diabetes mellitus | Q34450063 |
| | Nitric oxide in hypertension | Q34591297 |
| | High prevalence of undiagnosed obstructive sleep apnoea in the general population and methods for screening for representative controls | Q34645516 |
| | The genetics of obstructive sleep apnoea | Q57253489 |
| | Depression, Obstructive Sleep Apnea and Psychosocial Health | Q60624619 |
| | Characterization of the role of nitric oxide and its clinical applications | Q84432608 |
| | Interaction between endothelial nitric oxide synthase rs1799983, cholesteryl ester-transfer protein rs708272 and angiopoietin-like protein 8 rs2278426 gene variants highly elevates the risk of type 2 diabetes mellitus and cardiovascular disease | Q89421151 |
| | The polymorphism G894 T of endothelial nitric oxide synthase (eNOS) gene is associated with susceptibility to essential hypertension (EH) in Morocco | Q90575937 |
| | Obstructive sleep apnoea syndrome--an oxidative stress disorder | Q35066278 |
| | Nitric oxide (NO) and obstructive sleep apnea (OSA). | Q35178118 |
| | Nitric Oxide Bioavailability in Obstructive Sleep Apnea: Interplay of Asymmetric Dimethylarginine and Free Radicals. | Q35625951 |
| | GCH1, BH4 and pain | Q35747905 |
| | Obstructive Sleep Apnea, Oxidative Stress, and Cardiovascular Disease: Evidence from Human Studies | Q35763744 |
| | Enzymes of the L-arginine to nitric oxide pathway | Q35909698 |
| | Endothelial nitric oxide synthase (G894T) gene polymorphism in a random sample of the Egyptian population: comparison with myocardial infarction patients | Q36092727 |
| | Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation | Q36203132 |
| | GCH1-polymorphism and pain sensitivity among women with provoked vestibulodynia | Q36373554 |
| | Allele, Genotype and Haplotype Structures of Functional Polymorphic Variants in Endothelial Nitric Oxide Synthase (eNOS), Angiotensinogen (ACE) and Aldosterone Synthase (CYP11B2) Genes in Healthy Pregnant Women of Indian Ethnicity | Q36760671 |
| | Association of anthracycline-related cardiac histological lesions with NADPH oxidase functional polymorphisms | Q36804526 |
| | Increased prevalence of sleep-disordered breathing in adults | Q36805068 |
| | Mechanisms of endothelial dysfunction in obstructive sleep apnea | Q37145667 |
| | Clinical genetics of functionally mild non-coding GTP cyclohydrolase 1 (GCH1) polymorphisms modulating pain and cardiovascular risk | Q37178535 |
| | Association of eNOS Gene Polymorphisms G894T and T-786C with Risk of Hepatorenal Syndrome | Q37198473 |
| | Obstructive sleep apnea syndrome: from phenotype to genetic basis. | Q37236193 |
| | eNOS, metabolic syndrome and cardiovascular disease. | Q37317509 |
| | Nocturia and snoring: predictive symptoms for obstructive sleep apnea | Q37623501 |
| | Arginase activity and nitric oxide levels in patients with obstructive sleep apnea syndrome | Q37676877 |
| | Polymorphisms of genes in nitric oxide-forming pathway associated with ischemic stroke in Chinese Han population | Q37728756 |
| | Obstructive sleep apnea: diagnosis, epidemiology, and economics | Q37783634 |
| | Sleep apnoea and metabolic dysfunction | Q38133503 |
| | Central role of eNOS in the maintenance of endothelial homeostasis | Q38261420 |
| | Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy. | Q41763148 |
| | Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice. | Q42976945 |
| | STOP-Bang Questionnaire: A Practical Approach to Screen for Obstructive Sleep Apnea | Q43506370 |
| | Plasma Levels of Nitric Oxide and L-Arginine in Sleep Apnea Patients: Effects of nCPAP Treatment | Q44591000 |
| | C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils | Q44840248 |
| | A functional polymorphism of the GTP cyclohydrolase 1 gene predicts attention performance. | Q45122112 |
| | The role of nitric oxide in stroke | Q47164628 |
| | Awareness and knowledge of obstructive sleep apnea among the general population | Q47706461 |
| | NADPH oxidase p22phox polymorphisms and oxidative stress in patients with obstructive sleep apnoea. | Q48286304 |
| | Role of nitric oxide synthase gene intron 4 and exon 7 polymorphisms in obstructive sleep apnea syndrome | Q48428510 |
| | Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. | Q48708402 |
| | Obstructive sleep apnea: current perspectives. | Q49374416 |
| | Clinical consequences and economic costs of untreated obstructive sleep apnea syndrome. | Q51729551 |
| | Association between the nicotinamide adenine dinucleotide phosphate oxidase p22phox gene -A930G polymorphism and intracerebral hemorrhage. | Q54177980 |
| | The genetic association between iNOS and eNOS polymorphisms and gastric cancer risk: a meta-analysis. | Q55311825 |
| | Sleep–Related Breathing Disorders in Adults: Recommendations for Syndrome Definition and Measurement Techniques in Clinical Research | Q55885389 |
| P433 | issue | 1 | |
| P921 | main subject | obstructive sleep apnea | Q16606552 |
| P304 | page(s) | 18664 | |
| P577 | publication date | 2019-12-09 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | GCH1 (rs841) polymorphism in the nitric oxide-forming pathway has protective effects on obstructive sleep apnea | |
| P478 | volume | 9 | |